INO

INO

USD

Inovio Pharmaceuticals Inc. Common Stock

$2.430+0.000 (0.000%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.430

Máximo

$2.575

Mínimo

$2.410

Volume

1.91M

Fundamentos da empresa

Capitalização de mercado

129.1M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

1.60M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.3Atual $2.430Máximo $5.8

Notícias relacionadas

PR Newswire

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver mais
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
PR Newswire

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver mais
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver mais
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver mais
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
PR Newswire

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Ver mais
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine